Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

568 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Response to letter regarding article, “histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid”.
Zhao L, Chen CN, Hajji N, Oliver E, Cotroneo E, Wharton J, Wilkins MR, Wang D, Li M, Stenmark KR, McKinsey TA, Buttrick P. Zhao L, et al. Among authors: wilkins mr. Circulation. 2013 Apr 9;127(14):e540. doi: 10.1161/circulationaha.112.154757. Circulation. 2013. PMID: 23691553 No abstract available.
Emerging therapies for pulmonary arterial hypertension.
Ali O, Wharton J, Gibbs JS, Howard L, Wilkins MR. Ali O, et al. Among authors: wilkins mr. Expert Opin Investig Drugs. 2007 Jun;16(6):803-18. doi: 10.1517/13543784.16.6.803. Expert Opin Investig Drugs. 2007. PMID: 17501693 Review.
Therapeutic targets in pulmonary arterial hypertension.
Rhodes CJ, Davidson A, Gibbs JS, Wharton J, Wilkins MR. Rhodes CJ, et al. Among authors: wilkins mr. Pharmacol Ther. 2009 Jan;121(1):69-88. doi: 10.1016/j.pharmthera.2008.10.002. Epub 2008 Oct 28. Pharmacol Ther. 2009. PMID: 19010350 Review.
568 results